Search clinical trials for: gemtuzumab
Total 735 results
-
Hospices Civils de LyonNot yet recruiting
-
Institut für Klinische Krebsforschung IKF GmbH...Trium Analysis Online GmbHCompletedStomach Cancer | Gastroesophageal Junction CancerGermany
-
Leeds Cancer Centre at St. James's University HospitalCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAcute Myeloid Leukemia
-
Weill Medical College of Cornell UniversityCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Guangdong Provincial People's HospitalRecruitingNeoadjuvant Therapies for HER2+ Breast CancerChina
-
Grupo Cooperativo de Estudio y Tratamiento de las...CompletedNovo Acute Myeloid LeukemiaSpain
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
Genentech, Inc.Approved for marketing
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Puerto Rico
-
The University of New South WalesCompletedMyelodysplastic Syndromes | LeukemiaUnited Kingdom
-
University of OxfordBoehringer Ingelheim; Prostate Cancer UKActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterUnited States Department of Defense; Genentech, Inc.CompletedBreast Cancer Metastases | HER2 Positive BreastUnited States
-
Goethe UniversityCompletedLymphoma, Lymphoblastic | Adult Acute Lymphocytic Leukemia T-cellGermany
-
H. Lee Moffitt Cancer Center and Research InstituteWithdrawnBreast CancerUnited States
-
University of AlbertaJuvenile Diabetes Research FoundationCompleted
-
M.D. Anderson Cancer CenterWithdrawnLymphoma | Hodgkin's Disease
-
Centre Antoine LacassagneAcute Leukemia French AssociationNot yet recruiting
-
Gilead SciencesCompleted
-
Fundacio Clinic BarcelonaRoche Pharma AG; SOLTI Breast Cancer Research GroupRecruitingStage I Breast Cancer | HER2-positive Breast CancerSpain
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedChronic Lymphocytic LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Queen Mary University of LondonGilead SciencesUnknownRecurrent or Refractory B Cell Acute Lymphoblastic LeukaemiaUnited Kingdom
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2-PositiveRecurrent or Metastatic Breast Cancer
-
Massachusetts General HospitalDana-Farber Cancer Institute; TakedaNot yet recruiting
-
Gilead SciencesCompletedPrimary Sclerosing Cholangitis (PSC)United States, Belgium, Canada, Germany, United Kingdom, Italy, Spain, Denmark, Netherlands, Sweden
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Russian Federation, Poland, Croatia, United Kingdom
-
National Institute of Diabetes and Digestive and...CompletedEffectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted KidneysGraft Rejection | Kidney DiseaseUnited States
-
Hospital Universitario Dr. Jose E. GonzalezCompletedIdiopathic Thrombocytopenic Purpura | Anemia, Hemolytic, AutoimmuneMexico
-
LLS PedAL Initiative, LLCAbbVie; Roche-Genentech; Princess Maxima Center for Pediatric Oncology (European... and other collaboratorsRecruitingAcute Myeloid LeukemiaUnited States, Canada, Denmark, Spain, Belgium, Australia, France, New Zealand, Netherlands, Czechia, Norway, Switzerland, Austria, Portugal, Italy, Sweden, Israel
-
University of WashingtonPfizerRecruitingAcute Myeloid LeukemiaUnited States
-
Sascha MüllerCompleted
-
Hoffmann-La RocheCompleted
-
Peking University Cancer Hospital & InstituteRecruitingHER2-positive Metastatic Breast Cancer | Previously Treated With Trastuzumab | Trastuzumab Combined With Pertuzumab and ChemotherapyChina
-
Gilead SciencesCompletedNon-Hodgkin's LymphomaUnited States
-
Technische Universität DresdenAbbVie; University Hospital HeidelbergNot yet recruitingAcute Myeloid LeukemiaGermany
-
University Hospital, Udine, ItalyCompleted
-
Hospital Universitario Dr. Jose E. GonzalezCompletedGraft vs Host DiseaseMexico
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, Denmark, Canada, United States, Netherlands, Argentina, Austria, Belgium, Brazil, Croatia, Czech Republic, France, Germany, Israel, Italy, Mexico, Poland, Russian Federation, Serbia, Spain, Sweden, Ukraine, United Kingdom
-
Roswell Park Cancer InstitutePfizerActive, not recruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
University Hospital MuensterGenzyme, a Sanofi CompanyCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Genentech, Inc.Completed
-
Mahidol UniversityBayerTerminatedPeripheral T-Cell LymphomaThailand
-
Phramongkutklao College of Medicine and HospitalBayerTerminated
-
CABYCBayer; Genzyme, a Sanofi Company; Fundacion Clinic per a la Recerca Biomédica; Grupo... and other collaboratorsWithdrawnChronic Lymphocytic Leukaemia | Patients Resistant to a Purine Analogous | Patients Relapsed With Purines TherapySpain
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia | Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Adult Acute Myeloid Leukemia With Maturation | Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22)... and other conditionsUnited States
-
Robert Redner, MDPfizerActive, not recruiting
-
Queen Mary University of LondonActive, not recruiting
-
Queen Mary University of LondonTerminated